Halozyme Therapeutics

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Halozyme Therapeutics
Type Public (NASDAQHALO)
Industry Biopharmaceutical
Founded 1998
Headquarters San Diego, California, USA
Key people Gregory I. Frost, Ph.D., President & CEO
Products Biologics
Revenue Increase$ 3,799,521 USD (2007)
Employees 130
Website www.halozyme.com

Halozyme Therapeutics, based in San Diego, California, is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets.